volume 11 issue 4 pages 2101844

Engineering DNA Nanostructures to Manipulate Immune Receptor Signaling and Immune Cell Fates

Publication typeJournal Article
Publication date2021-11-20
scimago Q1
wos Q1
SJR2.328
CiteScore14.8
Impact factor9.6
ISSN21922640, 21922659
Pharmaceutical Science
Biomaterials
Biomedical Engineering
Abstract
Immune cells sense, communicate, and logically integrate a multitude of environmental signals to make important cell-fate decisions and fulfill their effector functions. These processes are initiated and regulated by a diverse array of immune receptors and via their dynamic spatiotemporal organization upon ligand binding. Given the widespread relevance of the immune system to health and disease, there have been significant efforts toward understanding the biophysical principles governing immune receptor signaling and activation, as well as the development of biomaterials which exploit these principles for therapeutic immune engineering. Here, how advances in the field of DNA nanotechnology constitute a growing toolbox for further pursuit of these endeavors is discussed. Key cellular players involved in the induction of immunity against pathogens or diseased cells are first summarized. How the ability to design DNA nanostructures with custom shapes, dynamics, and with site-specific incorporation of diverse guests can be leveraged to manipulate the signaling pathways that regulate these processes is then presented. It is followed by highlighting emerging applications of DNA nanotechnology at the crossroads of immune engineering, such as in vitro reconstitution platforms, vaccines, and adjuvant delivery systems. Finally, outstanding questions that remain for further advancing immune-modulatory DNA nanodevices are outlined.
Found 
Found 

Top-30

Journals

1
2
Small
2 publications, 7.69%
Applied Physics Reviews
1 publication, 3.85%
Advanced Therapeutics
1 publication, 3.85%
Nano Letters
1 publication, 3.85%
Nanoscale
1 publication, 3.85%
Advanced Drug Delivery Reviews
1 publication, 3.85%
JACS Au
1 publication, 3.85%
Nature Nanotechnology
1 publication, 3.85%
Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology
1 publication, 3.85%
Cell Reports Methods
1 publication, 3.85%
ACS Polymers Au
1 publication, 3.85%
ACS Nano
1 publication, 3.85%
Materials Futures
1 publication, 3.85%
TrAC - Trends in Analytical Chemistry
1 publication, 3.85%
Chinese Journal of Chemistry
1 publication, 3.85%
Advanced Science
1 publication, 3.85%
Nucleic Acids Research
1 publication, 3.85%
Nanoscale Horizons
1 publication, 3.85%
Smart Materials in Medicine
1 publication, 3.85%
1
2

Publishers

1
2
3
4
5
6
7
Wiley
7 publications, 26.92%
American Chemical Society (ACS)
4 publications, 15.38%
Elsevier
4 publications, 15.38%
Cold Spring Harbor Laboratory
4 publications, 15.38%
Royal Society of Chemistry (RSC)
2 publications, 7.69%
AIP Publishing
1 publication, 3.85%
Springer Nature
1 publication, 3.85%
IOP Publishing
1 publication, 3.85%
Oxford University Press
1 publication, 3.85%
1
2
3
4
5
6
7
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
26
Share
Cite this
GOST |
Cite this
GOST Copy
Tseng C. Y. et al. Engineering DNA Nanostructures to Manipulate Immune Receptor Signaling and Immune Cell Fates // Advanced healthcare materials. 2021. Vol. 11. No. 4. p. 2101844.
GOST all authors (up to 50) Copy
Tseng C. Y., Wang W. X., Douglas T. R., Chou L. Y. T. Engineering DNA Nanostructures to Manipulate Immune Receptor Signaling and Immune Cell Fates // Advanced healthcare materials. 2021. Vol. 11. No. 4. p. 2101844.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1002/adhm.202101844
UR - https://doi.org/10.1002/adhm.202101844
TI - Engineering DNA Nanostructures to Manipulate Immune Receptor Signaling and Immune Cell Fates
T2 - Advanced healthcare materials
AU - Tseng, Chung Yi
AU - Wang, Wendy Xueyi
AU - Douglas, Travis Robert
AU - Chou, Leo Y T
PY - 2021
DA - 2021/11/20
PB - Wiley
SP - 2101844
IS - 4
VL - 11
PMID - 34716686
SN - 2192-2640
SN - 2192-2659
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2021_Tseng,
author = {Chung Yi Tseng and Wendy Xueyi Wang and Travis Robert Douglas and Leo Y T Chou},
title = {Engineering DNA Nanostructures to Manipulate Immune Receptor Signaling and Immune Cell Fates},
journal = {Advanced healthcare materials},
year = {2021},
volume = {11},
publisher = {Wiley},
month = {nov},
url = {https://doi.org/10.1002/adhm.202101844},
number = {4},
pages = {2101844},
doi = {10.1002/adhm.202101844}
}
MLA
Cite this
MLA Copy
Tseng, Chung Yi, et al. “Engineering DNA Nanostructures to Manipulate Immune Receptor Signaling and Immune Cell Fates.” Advanced healthcare materials, vol. 11, no. 4, Nov. 2021, p. 2101844. https://doi.org/10.1002/adhm.202101844.